Abstract
“Maskne” is a new term coined during the 2020 COVID‐19 pandemic. It refers to a subset of acne mechanica, deserving consideration in view of widespread reusable fabric mask‐wearing to control the pandemic worldwide. Understanding of underlying pathophysiology directly relates to the novel skin microenvironment and textile–skin friction created by mask‐wearing, distinct from nontextile‐related acne mechanica previously linked to wearing of headgear. Specifically, the occlusive microenvironment leads to microbiome dysbiosis, which is linked to various dermatological conditions. Additional textile–skin interactions include factors such as breathability, stickiness sensations, moisture saturation, and hygiene maintenance. Increased skin temperatures can trigger sweat/heat‐related dermatoses, and ear loops potentially trigger pressure‐induced dermatoses. Important therapeutic considerations include increased skin irritation potential of conventional acne treatments under occlusion, exacerbation of chronic dermatoses, that is, perioral dermatitis, rosacea, and eczema, and susceptibility of these same patient groups to heightened discomfort with mask‐wearing. Cotton, as the traditional fabric of choice for dermatology patients, has limited benefits in the context of face masks – increased subjective discomfort relates to increased moisture saturation and stickiness, inevitable because of high biofluid load of the nasal and oral orifices. Prolonged textile–skin contact time, directly proportional to the risk of maskne, can be an opportunity for the application of biofunctional textiles.
COVID‐19, a respiratory disease caused by the SARS‐CoV‐2 virus, was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. In light of estimates that approximately one half of new infections are transmitted by persons who have no symptoms, universal mask‐wearing has become one of the public health recommendations critical to reducing respiratory transmission of SARS‐CoV‐2 virus.
Mask acne or “maskne” 1 , which has arisen during the 2020 COVID‐19 pandemic, refers to a form of acne mechanica arising from textile–skin friction. “Maskne” is deserving consideration in view of widespread reusable textile mask‐wearing to limit the spread of biofluids and, hence, the risk of contagion because of environmental contamination. Skin microbiota is influenced by genetic and external factors such as environment, pH, and temperature, 2 all of which are modified with mask‐wearing and retention of biofluids. This review paper addresses the impact of fabric mask‐wearing on the skin microbiome and dermatological conditions as well as the therapeutic role of biofunctional textiles in improving the skin microenvironment. A textile is defined as any material that is woven. These materials can be synthetic (i.e., plastic‐derived) or natural fibers (i.e., cotton, linen, and silk). The scope of this review also includes synthetic textiles such as polyester, that is, plastic‐derived types of materials, which are also identified as textiles.
Skin microbiome
Bacteria: The disruption of the healthy skin microbiome associated with mask‐wearing has profound implications on several dermatological conditions such as eczema, 3 acne, 4 and perioral dermatitis, 5 with bacterial dysbiosis implicated in its pathogenesis. Staphylococcus aureus colonization has a well‐established superantigen effect on eczema flare‐ups and has been implicated in various studies involving acne pathogenesis. 4 Gram‐negative folliculitis is a common complication of acne and can result in pustular eruptions and requires treatment with broad‐spectrum antibiotics. Our latest understanding of acne pathogenesis has shifted from Propionibacterium acnes to Cutibacterium acnes (C. acnes) colonization of sebaceous follicles. Dysbiosis of the skin microbiota leads to selection of virulent and pathogenic C. acnes strains and activation of innate immunity causing cutaneous inflammation. 6 Fusobacteria has been implicated in the pathogenesis of perioral dermatitis successfully treated with β‐lactam antibiotics in those who were tetracycline‐intolerant. 7
Fungal organisms: Proliferation of malassezia furfur, otherwise a healthy skin commensal, plays an important etiopathogenic role in the development of seborrheic dermatitis 8 as well as pityrosporum folliculitis, a clinical mimic of acne. 9 , 10
Others: There is a statistically significant association between demodex mite density and rosacea. 11 , 12 , 13 The emergence of ivermectin as a key therapy for rosacea supports the role of Demodex mites in the etiopathogenesis of rosacea. An altered skin microbiome will influence the interaction of demodex with various microorganisms, affecting the host immune system modulation response. 11 , 12 , 13
Dermatoses associated with heat/sweat
Fabric mask wear will increase skin temperatures and lead to increased sweat retention in normal individuals and worsen symptoms in those with facial hyperhidrosis. 14 Sweat allergy plays a role in the exacerbation of atopic dermatitis (AD) because of specific IgE‐mediated (type 1) hypersensitivity to sweat contents. 15 The effects of increased skin temperature can trigger conditions such as miliaria rubra and cholinergic urticaria. The moist warm microenvironment created by mask‐wearing increases the susceptibility of skin to fungal/yeast infections including candidiasis and malassezia, both common commensal of healthy skin. Intertrigo 16 , 17 traditionally associated with flexural areas, such as digital web spaces, axilla, groin, and inframammary folds, can be caused by microorganism overgrowth and is exacerbated by frictional dermatitis. Causative organisms implicated include candida, group A beta‐hemolytic streptococcus, 18 Corynebacterium minutissimum, and pseudomonas aeruginosa. 16 , 19 Mask‐wearing potentially introduces a “new” intertriginous area which is susceptible to similar infections, in particular with microbial communities like Staphylococcus and Corynebacteria, which favor moist regions. 2
Allergic contact dermatitis and harmful chemical exposure associated with textiles
The widespread manufacturing of various types of fabric face masks is to be regarded as part of the largely unregulated garment industry, with regard to fabric safety/skin tolerability, in contrast to personal protective equipment. It is reasonable to hypothesize that textile dyes will influence the development of allergic contact dermatitis over areas in contact with the face mask. Disperse dyes are a leading cause of textile‐related allergic patch test positivity. 20 Given the close proximity and occlusive effect of the mask to facial skin and the nasal and oral mucosal passages, as well as the use of potentially allergenic dispersed dyes in garment textiles, it may be prudent to consider dermatological recommendations for fabrics used for face masks. Existing textile certification bodies currently exist but are not mandated for manufacturers of face masks. This is in line with regulation of cosmetic products used in the personal care market, that is, the Personal Care Products Safety Act, which allows tracking, reporting of adverse events as well as the care of patients who are uniquely vulnerable to certain chemicals. 21 Benzothiazole, its derivatives, and other potentially hazardous chemicals are common textile contaminants in the garment industry. Using an artificial skin mimicking model membrane, Strat‐M®, a study by Iadaresta et al. 22 in 2018 demonstrated that benzothiazole, a carcinogen (also applied to other chemical contaminants), was released from textile materials, where it subsequently penetrated through the skin and further entered the human body systemically. Textile contaminants are potential health risks via dermal permeation to reach the systemic circulation. 23
Therapeutic considerations
Cleansing: Gentle cleansers with antibacterial active ingredients for maintenance of a healthy skin microbiome.
Leave‐on skincare: Avoid alcohol, salicylic acid, alpha‐hydroxy acids, and retinols in leave‐on acne skincare formulations because of increased risk of irritant contact dermatitis under prolonged occlusion.
Moisturizers: Serum, mist, lotion, and cream‐based vehicles, preferred over ointments. Moisturizers are essential in the maintenance of a healthy skin barrier function and reduce disruption of the skin microbiome, besides acting as a shield against external triggers. Humectants and “Prescription Emollient Devices (PEDs)” 24 should be the standard of care for moisturizers as opposed to emollient or occlusive active ingredients. Examples of PEDs include optimal ceramide/lipid mixtures with anti‐inflammatory ingredients such as glycyrrhetinic acid. Traditional humectants containing lactic acid and urea should be avoided, as these interact with sweat and moisture to alter the pH of skin under occlusion, resulting in irritant contact dermatitis. Examples of humectants that reduce transepidermal water loss without any irritation when worn under occlusion are natural moisturizing factors, sodium hyaluronate, and polyglutamic acid. Occlusives (e.g., petrolatum, mineral oil, and dimethicone) and emollients (lanolin, glycerol stearate, glyceryl stearate, and soy sterols) can both trigger occlusion acne in the case of maskne. For individuals with hyperhidrosis, excessive oily, acne‐prone skin, cream to powder moisturizer formulas may be helpful in maintaining an intact skin barrier to prevent skin inflammation under occlusion. 25
Topical acne treatments: Chemical/synthetic active ingredients, such as benzoyl peroxide, salicylic acid, sulfur, alpha‐hydroxy acids, and retinoids, have a higher risk of inducing irritant contact dermatitis under occlusive face mask wear. In addition, benzoyl peroxide has a bleaching effect on fabrics. Evidence‐based botanical active ingredients, which work via anti‐inflammatory effects, regulation of sebum production, and broad‐spectrum antimicrobial activity, are recommended for maskne treatment. 1 Use of powder formulations for acne may be preferred under occlusion to absorb excess moisture, 25 especially in individuals with facial hyperhidrosis. Zinc oxide formulations have broad antimicrobial properties effective for prevention and treatment of acne, and are stable in powder formulations. 26 Hydrogel carrier formulations of retinoid/antibiotic combination topicals can minimize local irritation by ensuring better drug tolerance and efficacy 27 in addition to providing an optimal wound healing environment. It may also provide effective barrier protection to reduce skin–textile friction and secondary bacterial infection.
Sunscreen: Current recommendations of broad‐spectrum SPF 50+ topical sunscreen and its 3–4 hourly reapplication rate are impractical under long periods of face mask wear especially outdoors. Chemical sunscreens can induce sensitization because of photodegradation, worse in individuals with atopy 28 when in contact with sweat/moisture under occlusion. Water‐resistant sunscreen with high lipophilic/hydrophilic ratios increases comedogenicity. 28 , 29 Ultraviolet protective (UPF) 50+ fabrics used for mask wear should be the principal intervention for broad‐spectrum sun protection for the lower half of the face during the COVID‐19 pandemic, 1 to improve patient compliance to photoprotection and incentivize mask‐wearing, also eliminating periodic reapplication of sunscreens.
-
Impact of face mask material/design on skin microenvironment
Textile–skin interactions: Natural fibers, such as cotton, linen, silk, and lyocell, offer greater breathability compared to synthetic fibers by wicking moisture away from skin. These may be beneficial for keeping the surface of skin dry and reducing microorganism overgrowth. However, natural fibers increase saturation levels. This increases symptoms of discomfort and weight. The perceived stickiness of the fabric can be measured by accumulated stickiness magnitude, ASM. 30 Synthetic fabrics that have been treated for cooling coefficient, moisture, and air permeability, also known as biofunctional textiles, 31 have a high evaporation coefficient without the fabric weighing down, an important factor in ensuring comfort. Sensitive skin possesses heightened neurosensory input that increases susceptibility to cutaneous sensory stimulants. 32 Textile–skin friction is an established trigger for several dermatological conditions, that is, AD, acne mechanica, frictional dermatitis, and postinflammatory hyperpigmentation. It may worsen symptoms in inflammatory conditions such as seborrheic dermatitis, perioral dermatitis, and rosacea. Fabrics with lower thread count as opposed to those with higher thread count will cause increased friction against skin. The fabric should have a smooth surface and a tight weave rather than loose weaves, which cause an irregular surface. Tightly woven fabrics also innately have higher UPF. Dark colors retain heat and increase skin temperature, which affects skin comfort and worsens heat‐sensitive conditions such as AD, cholinergic urticaria, hyperhidrosis, miliaria rubra, and rosacea.
Design: A smooth‐surfaced design with minimal folds is recommended 1 for minimal textile–skin friction, with a drawstring ear loop system to allow for individual adjustment. The surgical mask pattern with expandable folds accommodates various head sizes and face shapes but is not comfortable in the form of thicker textiles (used in reusable fabric masks) following the same pattern. The increased stitching and seams involved in creating the folds may reduce durability. To allow for maximal breathability and comfort while speaking, a pattern with two separate panels of the fabric follows the contour of the nose bridge and allows for comfortable air movement around the nose while minimizing spread of droplets. Based on the principle of an ideal fabric face mask offering UPF protection, the design facilitates maximum coverage of available facial skin surface area, consistent with current European recommendations for the design of UV‐protective clothing. 33
Contact dermatitis: Metallic nasal bridges offer no additional function and can cause nickel sensitization/contact allergy to the metal piece. 34 Ear loops should be latex‐free 35 alternatives such as spandex (polyurethane polymer). Adjustable rather than stretchable properties are preferred to avoid pressure and friction on the retroauricular region when worn for prolonged periods. This can predispose or aggravate abrasions, frictional dermatitis, postinflammatory hyperpigmentation, flexural eczema, and pressure dermographism. Rather than elastics, an adjustable threadable flat‐surfaced bead can be used to hold the face mask loops in place, a variant of a drawstring system. 1 Spherical beads protrude on skin and can cause frictional dermatitis. Drawstring forms of adjustable ear loops are preferred over ribbon ties, as these are prone to slip off, reduce a snug fit of the face mask, and cannot be quickly re‐worn in common social circumstances.
Hygiene: Reusable fabric mask wear poses the practical challenge of how to hygienically store the mask when one is exercising, eating, or drinking. To increase compliance of face mask‐wearing for the general public, immediately before/after the said activities, doctors can recommend the quick act of looping it under the jawline (vs. storage in a separate bag) (Fig. 1). This provides a natural hold, minimizing risks of mask dislocation and need for constant adjustment (i.e., surface contamination). Given the daily wear of the face mask and contamination with respiratory droplets and saliva, the face mask should withstand daily laundering at high temperatures to destroy microorganisms that cause odor/disease. Synthetic fibers like polyester and polyurethane are more durable than natural fibers, the latter prone to distortion/disintegration, affecting efficacy. For hygienic and convenient disinfection of fabric masks when daily washing is not possible, applying a hot iron (356–428 Fahrenheit at standard settings) on both sides of the fabric will be sufficient to kill respiratory viruses, including the COVID‐19 virus 36 as well as minimize pathogenic bacterial growth. Biofunctional textiles confer self‐cleaning benefits relevant for a frequent wear, high biofluid contamination garment like the reusable fabric mask. 37
Distinct complications from systemic pharmacotherapy: The use of traditional systemic pharmacotherapy for moderate or severe maskne may face unique complications distinct from acne vulgaris. The side effect profile of isotretinoin, a widely used systemic medication for the treatment of moderate/severe acne, includes development of eczema, cheilitis, and increased bacterial infections, that is, S. aureus. 38 Individuals on isotretinoin are prone to frictional dermatitis, exacerbation of retinoid dermatitis, cheilitis, and are more susceptible to cutaneous infections. 39 The warm and moist microenvironment increases the risk of microorganism overgrowth and secondary infections, such as impetigo, Gram‐negative folliculitis, and malassezia folliculitis.
Figure 1.
Proposed method of mask handling when eating/drinking/exercising. (a) The fabric face mask for public use should cover the nose and the mouth when worn, for protection of the environment from biofluid contamination. (b) When eating/drinking/exercising, the mask can be conveniently looped under the jawline which forms a natural hold for storage, minimizing the risk of further contamination and enabling quick re‐wearing. (c) Dangling a mask off one side of face while performing said activities is not recommended as it exposes biofluid for potential contamination of the environment
Potential of biofunctional textiles in microbiome dysbiosis
Given that textiles have prolonged contact with skin, research into functional textiles with intrinsic properties, such as antioxidative capacity and antimicrobial activity, will be relevant in dermatological applications. The current recommendation of the widespread use of reusable fabric masks is one such area.
Traditionally, dermatologists have recommended cotton as the only comfortable tissue suitable for patients with dermatological conditions. With the advancement of materials engineering, synthetic fibers with improved functions of breathability and waterproofing, and the added properties of quick‐dry, increased comfort (compared to cotton), surface modification with antimicrobial properties, have emerged as a complementary tool in dermatologic treatments. 40 Functional textiles (that maintain deliverable antimicrobial activity in vitro) 41 have been proposed as safe adjunct treatment for AD with some data published regarding their antimicrobial properties and clinical efficacy. 42 , 43 , 44 , 45
Relevant biofunctional textiles to dermatology were reviewed, via a search over the following databases, i.e. PubMed, ScienceDirect, and Google Scholar. The key words such as “textile dermatology”, “textile skin”, “zinc textile”, “zinc oxide textile”, “zinc textile dermatology”, “copper textile”, “copper oxide textile”, “copper textile dermatology”, “silver textile”, “silver textile dermatology”, “antibacterial textile”, “UV textile”, “antiaging textile”, “textile nanoparticles”, “atopic dermatitis textile”, “eczema textile”, and “acne textile” were utilized. A separate search with the word “textile” replaced by “fabrics” was also executed. All studies published over a 10 year duration from 2010 till September 2020 were analyzed.
Study selection. Studies describing synthesis of nanoparticles on textiles with subsequent analysis of acquired functions and studies containing clinical evidence of the effect of textiles impregnated with nanoparticles on skin condition were included into this review.
Study characteristics. All studies were analyzed with regard to the nature of nanoparticles utilized for textile modification, the type of textile, and the efficacy of modified textile in terms of its antimicrobial, antifungal, antiviral activity, UV protection, or antiaging properties. The results of individual studies were used per se and not analyzed (Table 1).
Table 1.
Review of in vitro and in vivo studies involving biofunctional textiles with antimicrobial properties
Reference | Material | Effect | |
---|---|---|---|
Textiles modified by Zn compounds | |||
In vitro studies | |||
Pandimurugan et al. (2017) 54 | ZnO NPs/cotton | Inhibits S. aureus, S. pyogenes, E. coli and K. aerogenes | |
Ghasemi et al. (2018) 55 | ZnO NPs/cotton | Inhibits S. aureus and E. coli | |
Khan et al. (2018) 56 | ZnO NPs/cotton | Inhibits E. coli and S. aureus and preserves UV properties up to 20 washing cycles | |
D'Agua et al. (2018) 57 | ZnO NPs/cotton | Inhibits MRSA, S. epidermidis, S. aureus and P. acnes | |
Shaheen et al. (2016) 58 | ZnO NPs/cotton | Inhibits S. aureus and E. coli | |
Souza et al. (2018) 59 | ZnO NPs/cotton | Inhibits S. aureus and P. aeruginosa | |
Ran et al. (2018) 60 | ZnO NPs/cotton | Inhibits G. cerinus | |
Salat et al. (2018) 61 | ZnO NPs/cellulose | Inhibits S. aureus after 60th laundry | |
Wang et al. (2016) 62 | ZnO NPs/cotton | Inhibits S. aureus and K. pneumoniae. UPF 50+ | |
Petkova et al. (2016) 63 | ZnO NPs/cotton | Inhibits S. aureus and E. coli | |
El‐Nahhal et al. (2020) 64 | ZnO NPs/cotton | Increases antimicrobial activity toward S. aureus and E. coli | |
Das et al. (2017) 65 | ZnO NPs/cotton | Inhibition of E. coli and S. aureus | |
Kar et al. (2019) 66 | ZnO NPs/cotton Khadi | Inhibits K. pneumoniae and S. aureus. UPF 20 | |
Huang et al. (2019) 67 | ZnO NPs/silk | Has UPF >50 | |
Nourbakhsh et al. (2018) 68 | ZnO NPs/polyester | Inhibits S. aureus and E. coli | |
Ashraf et al. (2016) 69 | ZnO NPs/polyester, cotton | Inhibits S. aureus | |
Paul et al. (2019) 70 | ZnSnO3/cotton | Inhibits Gram‐positive and Gram‐negative bacteria with UPF 45 | |
Amani et al. (2019) 71 | ZnO NPs/polyester | Inhibits E. coli, S. aureus and C. albicans | |
Preethi et al. (2020) 72 | ZnO NPs/cotton | Inhibits S. aureus, B. subtilis and E. coli | |
Fiedot‐Tobola et al. (2018) 73 | ZnO microparticles/polyethylene terephthalate, polyamide, polypropylene | Inhibits E. coli and S. aureus | |
Hassabo et al. (2019) 74 | Ag NPs/ZnO NPs/Cu NPs/cotton | Durable antibacterial and UV protection properties. | |
Holt et al. (2018) 75 | ZnCl2/polyester | Inhibits S. aureus even after abrasive washing | |
In vivo studies | |||
Wollina et al. (2009) 76 | Smartcel sensitive (ZnO NPs/cotton, lyocell, elastane) | Sleep improvement and pruritus alleviation was observed in neurodermatitis patients after 10 days | |
Hoefer et al. (2018) 77 | Smartcel sensitive (ZnO NPs/cotton, lyocell, elastane); Benevit Zinc+ (lyocell, ZnO NPs/Smartcel sensitive, spandex); DermaSilk (AEGIS 5772/silk); Padycare (polyamide, Ag NPs/lycra); Binamed (modal, Ag NP/polyester, lycra) | ZnO‐containing fabrics have stronger antibacterial activity than Ag‐containing samples, which are more effective in decreasing lesion severity, while silk fabrics alleviate pruritus and symptoms | |
Wiegand et al. (2013) 49 | Benevit Zink+ (lyocell, ZnO NPs/Smartcel sensitive, spandex) | Improved night sleep, pruritus, and AD severity | |
Textiles modified by Cu compounds | |||
In vitro studies | |||
Teli et al. (2013) 78 | Cu NPs/bamboo rayon | Inhibits S. aureus and E. coli after 50 washes | |
Hammer et al. (2012) 79 | Cu NPs/cotton | Inhibits T. rubrum, T. mentagrophytes and C. albicans | |
Sharma P et al. (2019) 80 | Cu NPs/cotton | Inhibits S. aureus and E. coli | |
Turalija et al. (2015) 81 | Cu2O microparticles/polyester | Inhibits S. aureus and K. pneumoniae | |
Bhutiya PL et al. (2018) 82 | Cu2O NPs/cellulose | Inhibits S. aureus, S. thermophilus, P. aeruginosa and E. coli | |
Vasantharaj S et al. (2019) 83 | CuO NPs/cotton | Inhibits S. aureus, E. coli, K. pneumoniae | |
Galani et al. (2016) 84 | Cu NPs/para‐aramide and polyester | Inhibits S. aureus, K. pneumoniae, P. aeruginosa, A. baumannii and E. faecium, P. aeruginosa and C. parapsilosis | |
Sójka‐Ledakowicz et al. (2016) 85 | CuSiO3/polypropylene and polylactide | Inhibits E. coli, S. aureus and C. albicans | |
Imai K et al. (2012) 86 | Cu2+/cotton | Inactivates avian influenza virus H5 subtype | |
In vivo studies | |||
Marcus et al. (2017) 87 | CuO NPs/linen, cotton and polyester | Reductions of 29.3, 55.5, 23.0, and 27.5% in the ATIEs, fever days, days of antibiotic treatment, and antibiotics. | |
Butler (2018) 88 | CuO NPs/linen, cotton and polyester | ~48% reductions in HCAI caused by C. difficile, ~32% reductions in HCAI caused by MDROs, and ~45% in the reduction of HCAI caused by C. difficile and MDROs combined | |
Lazary et al. (2014) 89 | CuO NPs/linen, cotton and polyester | A 24% reduction in HCAI, a 47% reduction in number of fever days and a 32.8% reduction in total number of days of antibiotic administration | |
Dykes (2015) 90 | CuO NPs/polyester | After 4 weeks, an increase in the mean net skin and biological elasticity of 31.4 and 20.7%, respectively, was observed | |
Gargiulio et al. (2012) 91 | CuO NPs/polyester | Amelioration of tinea pedis | |
Baek et al. (2012) 92 | CuO NPs/polyester | Decrease of crow's feet was observed after 4 weeks | |
Borkow et al. (2009) 93 | CuO NPs/polyester | Reduction of facial wrinkles and crow's feet/fine lines after 2 weeks | |
Textiles modified by Ag compounds | |||
In vitro studies | |||
Rehan et al. (2017) 94 | Ag NPs/cotton | Blocks UV and inhibits E. coli | |
Xu et al. (2017) 95 | Ag NPs/cotton | Inhibits S. aureus and E. coli. Stable after 50 laundering cycles | |
Emam et al. (2015) 96 | Ag NPs/cotton | Inhibits E. coli and S. aureus | |
Li et al. (2017) 97 | Ag NPs/cotton | Inhibits E. coli and S. aureus, has improved UPF values | |
El‐Rafie et al. (2014) 98 | Ag NPs/cotton | Inhibits S. aureus and E. coli after 20 washings | |
Zhang et al. (2013) 99 | Ag NPs/cotton | Inhibits S. aureus and E. coli after 50 washings | |
Gerba et al. (2016) 100 | Ag NPs/cotton | Inhibits salmonella, MRSA, P. acnes, T. mentagrophytes, Enterococcus, C. difficile and norovirus | |
Balakumaran et al. (2016) 101 | Ag NPs/cotton | Inhibits B. subtilis, S. aureus, K. pneumoniae and P. aeruginosa | |
Dhiman et al. (2015) 102 | Ag NPs/cotton | Inhibits S. aureus and E. coli | |
Pulit‐Prociak et al. (2016) 103 | Ag NPs/cotton | Inhibits S. cerevisiae | |
Shaheen et al. (2018) 104 | Ag NPs/cotton | Inhibits S. aureus, E. coli, C. albicans and fungi | |
Rodrigues et al. (2019) 105 | Ag NPs/cotton and polyester | Inhibits S. aureus, E. coli, C. albicans, C. glabrata and C. parapsilosis | |
Ali et al. (2011) 106 | Ag NPs/polyester | Inhibits S. aureus | |
Noor et al. (2019) 107 | Ag NPs/polyviscose | Inhibits E. coli | |
Mofidar et al. (2019) 108 | Ag NPs/polyacrylic acid fibers | Inhibits C. albicans and MRSA | |
Rehan et al. (2018) 109 | Ag/AgI NPs/viscose | Inhibits E. coli and S. aureus and has UV protection | |
Tremiliosi et al. (2020) 110 | Ag NPs/polyester‐cotton | Inhibits S. aureus, E. coli, C. albicans, SARS‐CoV‐2. | |
Ibănescu et al. (2014) 111 | Ag/ZnO NPs/cotton and cotton‐polyester | Inhibits S. aureus and M. luteus | |
Shin et al. (2014) 112 | Ag/Ag‐SiO2 NPs/polyester | Inhibits S. aureus and E. coli | |
Nischala et al. (2010) 113 | Ag‐SiO2/cotton | Inhibits E. coli | |
In vivo studies | |||
Juenger et al. (2006) 114 | Padycare (polyamide, Ag NPs/lycra) | Reduced clinical severity of AE and pruritus within a wearing period of 2 weeks | |
Park et al. (2012) 45 | Skin Doctor (TiO2–Ag NPs/algal cellulose) | Reduction in S. aureus colonization and decrease in TEWL | |
Araújo et al. (2013) 115 | Skin to skin (cotton, Ag NPs/algal cellulose) | Decreases up to 70% of itching. Quality of sleep improved to about 65%. | |
Fluhr et al. (2010) 47 | Ag NPs/algal cellulose | Reduction in S. aureus colonization and improved TEWL was observed during the first 4 weeks of the study | |
Srour et al. (2019) 41 | DermaSilk (AEGIS 5772/silk), Padycare (polyamide, Ag NPs/lycra), SkinProtect (Ag NPs/cotton and polyester), Binamed (modal, Ag NP/polyester, lycra), Platatex (Ag NPs/cotton and polyester), Pulmanova Bioactive (Ag NPs/cotton), Silver‐Skin (AgNPs/cotton and polyester), Best4Body (Ag NPs/cotton), Schiesser (Ag NPs/cotton), Medima Antisept (Ag NPs/cotton and polyamide), Sansita (micromodal, lycra and Ag NPs/cellulose) | Textiles coated by Ag NPs delivered durable antimicrobial activity unaffected by laundering | |
Hoefer et al. (2011) 116 | Ag NPs/polyester | No pathogenic germs occurred in the microflora of the subjects during 4 weeks | |
Daeschlein et al. (2010) 46 | Ag NPs/polyamide | Inhibited S. aureus and total bacterial colonization after 2 days of wearing without washing | |
Morand et al. (2019) 48 | Ag NPs/polyamide and elastane | Alleviated perineal folliculitis |
ATIE, antibiotic treatment initiation events; HCAI, health care‐associated infection; MDRO, multidrug‐resistant organisms; MRSA, methicillin‐resistant Staphylococcus aureus; NPs, nanoparticles; TEWL, transepidermal water loss.
Silver impregnated textiles exhibited significantly less S. aureus as well as total bacterial colonization after 2 days of wearing without washing, as compared with a placebo textile. 46 In a randomized controlled trial, silver‐loaded seaweed fiber was associated with an in vivo statistically significant reduction in S. aureus colonization and a pronounced improvement in barrier function (transepidermal water loss). 47 Given the pathophysiologic similarities of bacterial proliferation and chronic inflammation in both acne and hidradenitis suppurativa, Morand et al. treated a case of hidradenitis suppurativa with silver‐coated textiles with reported success. 48 ZnO‐functionalized textile fibers were associated with rapid improvement of AD severity, pruritus, and subjective sleep quality when AD patients wore the ZnO textiles, 49 postulated to be related to high antioxidative capacity of the ZnO textile, strong antibacterial activity, and good biocompatibility. Nanocrystalline silver dressings have demonstrated statistically significant wound healing benefits over traditional silver sulfadiazine and gauze dressings, because of its anti‐inflammatory effect. 50
Copper oxide impregnated textiles are broadly biocidal, self‐sterilizing, with efficacy against antibiotic‐resistant bacteria, including methicillin‐resistant S. aureus and vancomycin‐resistant Enterococci when used in the control of nosocomial infections and the spread of antibiotic‐resistant bacteria. 51 Impregnation of copper oxide into respiratory protective face masks also confers additional biocidal properties (anti‐influenza) apart from its inherent filtration properties and can significantly reduce the risk of hand or environmental contamination, and subsequent infection, because of improper handling and disposal of the masks. 52 Examples in dermatological applications include incorporation in antifungal socks for treatment of tinea pedis and anti‐demodex mite mattress covers for prevention of dust mite‐triggered allergies, with no demonstrable skin‐sensitizing properties. 51
Antibiotic resistance is an important concept in acne treatment, and it is currently recommended to use topical antibiotics in combination with benzoyl peroxide or retinoids to lower antibiotic resistance of P. acnes to erythromycin and clindamycin. 53 However, such formulations when worn under occlusive effects will increase the risk of irritant contact dermatitis. Given the recommendation for widespread mask‐wearing, it is reasonable to hypothesize increased incidence of maskne. It is important that the international dermatology community is made aware of how prescribing patterns may potentially influence the development of antibiotic resistance worldwide.
Role of dermatologists
Dermatologists should be aware of changes in the skin microbiome because of widespread fabric mask‐wearing and its influence on new and existing dermatological conditions. The antimicrobial functions of biofunctional textiles and the new social “norm” of widespread mask‐wearing present therapeutic opportunities for treatment of microbiome dysbiosis in maskne and chronic skin disorders, while decreasing the risk of antibiotic resistance in the population.
Several dermatological factors may influence noncompliance to mask‐wearing. Individual discomfort in the form of retained moisture, sensation of stickiness, and inconveniences experienced by the individual caused by difficulty in speaking or breathing may be related to the design and material of the mask. Sensitive skin patient populations may experience heightened sensations with frictional dermatitis. A poor understanding of infectious disease control methods may also be a contributory factor to noncompliance. Dermatological benefits of biofunctional textiles, such as UV protection, treatment of skin disease, and antiaging, can potentially be viewed as additional evidence‐based incentives for widespread face mask wear, 1 besides reducing the occurrence of common complications such as maskne and flare‐ups of existing dermatological conditions caused by face masks made of traditional textiles.
Conflict of interest: The author is the chief scientific advisor and owns Dr. TWL Dermaceuticals, a cosmeceutical, biofunctional textile research and development company.
Funding source: None.
References
- 1. Teo WL. Diagnostic and management considerations for 'Maskne' in the era of COVID‐19. J Am Acad Dermatol 2021; 84: 520–521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Dréno B, Araviiskaia E, Berardesca E, et al. Microbiome in healthy skin, update for dermatologists. J Eur Acad Dermatol Venereol 2016; 30: 2038–2047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Blicharz L, Rudnicka L, Samochocki Z. Staphylococcus aureus: an underestimated factor in the pathogenesis of atopic dermatitis? Postepy Dermatol Alergol 2019; 36: 11–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Khorvash F, Abdi F, Kashani HH, et al. Staphylococcus aureus in acne pathogenesis: a case‐control study. N Am J Med Sci 2012; 4: 573–576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Takiwaki H, Tsuda H, Arase S, et al. Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis. Clin Exp Dermatol 2003; 28: 531–534. [DOI] [PubMed] [Google Scholar]
- 6. Dréno B, Pécastaings S, Corvec S, et al. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol 2018; 32: 5–14. [DOI] [PubMed] [Google Scholar]
- 7. Ishiguro N, Maeda A, Suzuki K, et al. Three cases of perioral dermatitis related to fusobacteria treated with β‐lactam antibiotics. J Dermatolog Treat 2014; 25: 507–509. [DOI] [PubMed] [Google Scholar]
- 8. Barac A, Pekmezovic M, Milobratovic D, et al. Presence, species distribution, and density of Malassezia yeast in patients with seborrhoeic dermatitis ‐ a community‐based case‐control study and review of literature. Mycoses 2015; 58: 69–75. [DOI] [PubMed] [Google Scholar]
- 9. Rindaville B, Belazarian L, Levin NA, et al. Pityrosporum folliculitis: a retrospective review of 110 cases. J Am Acad Dermatol 2018; 78: 511–514. [DOI] [PubMed] [Google Scholar]
- 10. Del Rosso JQ, Silverberg N, Zeichner JA. When acne is not acne. Dermatol Clin 2016; 34: 225–228. [DOI] [PubMed] [Google Scholar]
- 11. Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin 2018; 36: 81–86. [DOI] [PubMed] [Google Scholar]
- 12. Gonzalez‐Hinojosa D, Jaime‐Villalonga A, Aguilar‐Montes G, et al. Demodex and rosacea: is there a relationship? Indian J Ophthalmol 2018; 66: 36–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Moran EM, Foley R, Powell FC. Demodex and rosacea revisited. Clin Dermatol 2017; 35: 195–200. [DOI] [PubMed] [Google Scholar]
- 14. Glaser DA, Hebert AA, Pariser DM, et al. Facial hyperhidrosis: best practice recommendations and special considerations. Cutis 2007; 79: 29–32. [PubMed] [Google Scholar]
- 15. Takahagi S, Tanaka A, Hide M. Sweat allergy. Allergol Int 2018; 67: 435–441. [DOI] [PubMed] [Google Scholar]
- 16. Kalra MG, Higgins KE, Kinney BS. Intertrigo and secondary skin infections. Am Fam Physician 2014; 89: 569–573. [PubMed] [Google Scholar]
- 17. Ndiaye M, Taleb M, Diatta BA, et al. Les étiologies des intertrigos chez l'adulte : étude prospective de 103 cas [Etiology of intertrigo in adults: A prospective study of 103 cases]. J Mycol Med 2017; 27: 28–32. [DOI] [PubMed] [Google Scholar]
- 18. Neri I, Bassi A, Patrizi A. Streptococcal intertrigo. J Pediatr 2015; 166: 1318. [DOI] [PubMed] [Google Scholar]
- 19. Morand A, Morand JJ. Pseudomonas aeruginosa en dermatologie [Pseudomonas aeruginosa in dermatology]. Ann Dermatol Venereol 2017; 144: 666–675. [DOI] [PubMed] [Google Scholar]
- 20. Coman G, Blickenstaff N, Edwards A, et al. Dermatotoxicologic clinical solutions: textile dye dermatitis patch testing. Cutan Ocul Toxicol 2015; 34: 68–71. [DOI] [PubMed] [Google Scholar]
- 21. Nguyen HP, Bergfeld WF, Forman HP, et al. Modernizing regulation of cosmetic products: reintroduction of the Personal Care Products Safety Act. J Am Acad Dermatol 2018; 79: 403–405. [DOI] [PubMed] [Google Scholar]
- 22. Iadaresta F, Manniello MD, Östman C, et al. Chemicals from textiles to skin: an in vitro permeation study of benzothiazole. Environ Sci Pollut Res Int 2018; 25: 24629–24638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Provisional peer‐reviewed toxicity values for benzothiazole. United States Environmental Protection Agency website. https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=338837. Accessed August 10, 2020.
- 24. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev 2017; 2: CD012119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Gunt HB, Levy SB, Lutrario CA. A natural cream‐to‐powder formulation developed for the prevention of diaper dermatitis in diaper‐wearing infants and children: barrier property and in‐use tolerance studies. J Drugs Dermatol 2018; 17: 566–570. [PubMed] [Google Scholar]
- 26. Bae JY, Park SN. Evaluation of anti‐microbial activities of ZnO, citric acid and a mixture of both against Propionibacterium acnes . Int J Cosmet Sci 2016; 38: 550–557. [DOI] [PubMed] [Google Scholar]
- 27. Zagórska‐Dziok M, Sobczak M. Hydrogel‐based active substance release systems for cosmetology and dermatology application. A Review. Pharmaceutics. 2020; 12: 396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Scheuer E, Warshaw E. Sunscreen allergy: a review of epidemiology, clinical characteristics, and responsible allergens [published correction appears in Dermatitis. 2006 Sep; 17(3):162]. Dermatitis 2006; 17: 3–11. [DOI] [PubMed] [Google Scholar]
- 29. Jain SK, Jain NK. Multiparticulate carriers for sun‐screening agents. Int J Cosmet Sci 2010; 32: 89–98. [DOI] [PubMed] [Google Scholar]
- 30. Tang KM, Chau KH, Kan CW, et al. Assessing the accumulated stickiness magnitude from fabric‐skin friction: effect of wetness level of various fabrics. R Soc Open Sci 2018; 5: 180860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Bartels VT. Physiological comfort of biofunctional textiles. Curr Probl Dermatol 2006; 33: 51–66. [DOI] [PubMed] [Google Scholar]
- 32. Draelos ZD. Sensitive skin: perceptions, evaluation, and treatment. Am J Contact Dermat 1997; 8: 67–78. [PubMed] [Google Scholar]
- 33. Van den Keybus C, Laperre J, Roelandts R. Protection from visible light by commonly used textiles is not predicted by ultraviolet protection. J Am Acad Dermatol 2006; 54: 86–93. [DOI] [PubMed] [Google Scholar]
- 34. Ahlström MG, Thyssen JP, Wennervaldt M, et al. Nickel allergy and allergic contact dermatitis: a clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis 2019; 81: 227–241. [DOI] [PubMed] [Google Scholar]
- 35. Wu M, McIntosh J, Liu J. Current prevalence rate of latex allergy: why it remains a problem? J Occup Health 2016; 58: 138–144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. World Health Organization website. https://www.who.int/csr/sars/survival_2003_05_04/en/. Accessed August 10, 2020.
- 37. Montazer M, Seifollahzadeh S. Enhanced self‐cleaning, antibacterial and UV protection properties of nano TiO2 treated textile through enzymatic pretreatment. Photochem Photobiol 2011; 87: 877–883. [DOI] [PubMed] [Google Scholar]
- 38. Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol 1987; 123: 606–608. [PubMed] [Google Scholar]
- 39. Khalil S, Bardawil T, Stephan C, et al. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. J Dermatolog Treat 2017; 28: 684–696. [DOI] [PubMed] [Google Scholar]
- 40. Brambilla L, Brena M, Tourlaki A. Textiles in dermatology: our experience and literature review. G Ital Dermatol Venereol 2016; 151: 266–274. [PubMed] [Google Scholar]
- 41. Srour J, Berg E, Mahltig B, et al. Evaluation of antimicrobial textiles for atopic dermatitis. J Eur Acad Dermatol Venereol 2019; 33: 384–390. [DOI] [PubMed] [Google Scholar]
- 42. Gauger A, Fischer S, Mempel M, et al. Efficacy and functionality of silver‐coated textiles in patients with atopic eczema [published correction appears in J Eur Acad Dermatol Venereol. 2006 Jul; 20(6):771]. J Eur Acad Dermatol Venereol 2006; 20: 534–541. [DOI] [PubMed] [Google Scholar]
- 43. Haug S, Roll A, Schmid‐Grendelmeier P, et al. Coated textiles in the treatment of atopic dermatitis. Curr Probl Dermatol 2006; 33: 144–151. [DOI] [PubMed] [Google Scholar]
- 44. Gauger A. Silver‐coated textiles in the therapy of atopic eczema. Curr Probl Dermatol 2006; 33: 152–164. [DOI] [PubMed] [Google Scholar]
- 45. Park KY, Jang WS, Yang GW, et al. A pilot study of silver‐loaded cellulose fabric with incorporated seaweed for the treatment of atopic dermatitis. Clin Exp Dermatol 2012; 37: 512–515. [DOI] [PubMed] [Google Scholar]
- 46. Daeschlein G, Assadian O, Arnold A, et al. Bacterial burden of worn therapeutic silver textiles for neurodermitis patients and evaluation of efficacy of washing. Skin Pharmacol Physiol 2010; 23: 86–90. [DOI] [PubMed] [Google Scholar]
- 47. Fluhr JW, Breternitz M, Kowatzki D, et al. Silver‐loaded seaweed‐based cellulosic fiber improves epidermal skin physiology in atopic dermatitis: safety assessment, mode of action and controlled, randomized single‐blinded exploratory in vivo study. Exp Dermatol 2010; 19: e9–e15. [DOI] [PubMed] [Google Scholar]
- 48. Morand M, Hatami A. Silver‐coated textiles in hidradenitis suppurativa: a case report. SAGE Open Med Case Rep 2019; 7: 2050313X19845212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Wiegand C, Hipler UC, Boldt S, et al. Skin‐protective effects of a zinc oxide‐functionalized textile and its relevance for atopic dermatitis. Clin Cosmet Investig Dermatol 2013; 6: 115–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 2010; 28: 580–588. [DOI] [PubMed] [Google Scholar]
- 51. Borkow G, Gabbay J, Lyakhovitsky A, et al. Putting copper into action: copper‐impregnated products with potent biocidal activities. FASEB J 2004; 18: 1728–1730. [DOI] [PubMed] [Google Scholar]
- 52. Borkow G, Zhou SS, Page T, et al. A novel anti‐influenza copper oxide containing respiratory face mask. PLoS One 2010; 5: e11295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Walsh TR, Efthimiou J, Dreno B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect Dis 2016; 16: e23–e33. [DOI] [PubMed] [Google Scholar]
- 54. Pandimurugan R, Thambidurai S. UV protection and antibacterial properties of seaweed capped ZnO nanoparticles coated cotton fabrics. Int J Biol Macromol 2017; 105: 788–795. [DOI] [PubMed] [Google Scholar]
- 55. Ghasemi N, Seyfi J, Asadollahzadeh MJ. Imparting superhydrophobic and antibacterial properties onto the cotton fabrics: synergistic effect of zinc oxide nanoparticles and octadecanethiol. Cellulose 2018; 25: 4211–4222. [Google Scholar]
- 56. Khan MZ, Baheti V, Ashraf M, et al. Development of UV protective, superhydrophobic and antibacterial textiles using ZnO and TiO2 nanoparticles. Fibers Polym 2018; 19: 1647–1654. [Google Scholar]
- 57. D'Água RB, Branquinho R, Duarte MP, et al. Efficient coverage of ZnO nanoparticles on cotton fibres for antibacterial finishing using a rapid and low cost in situ synthesis. New J Chem 2018; 42: 1052–1060. [Google Scholar]
- 58. Shaheen TI, El‐Naggar ME, Abdelgawad AM, et al. Durable antibacterial and UV protections of in situ synthesized zinc oxide nanoparticles onto cotton fabrics. Int J Biol Macromol 2016; 83: 426–432. [DOI] [PubMed] [Google Scholar]
- 59. Souza DAR, Gusatti M, Ternus RZ, et al. In situ growth of ZnO nanostructures on cotton fabric by solochemical process for antibacterial purposes. J Nanomater 2018; 2018: 9 pages. 10.1155/2018/9082191 [DOI] [Google Scholar]
- 60. Ran J, He M, Li W, et al. Growing ZnO nanoparticles on polydopamine‐templated cotton fabrics for durable antimicrobial activity and UV protection. Polymers 2018; 10: 495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Salat M, Petkova P, Hoyo J, et al. Durable antimicrobial cotton textiles coated sonochemically with ZnO nanoparticles embedded in an in‐situ enzymatically generated bioadhesive. Carbohydr Polym 2018; 189: 198–203. [DOI] [PubMed] [Google Scholar]
- 62. Wang C, Lv J, Ren Y, et al. Cotton fabric with plasma pretreatment and ZnO/Carboxymethyl chitosan composite finishing for durable UV resistance and antibacterial property. Carbohydr Polym 2016; 138: 106–113. [DOI] [PubMed] [Google Scholar]
- 63. Petkova P, Francesko A, Perelshtein I, et al. Simultaneous sonochemical‐enzymatic coating of medical textiles with antibacterial ZnO nanoparticles. Ultrason Sonochem 2016; 29: 244–250. [DOI] [PubMed] [Google Scholar]
- 64. El‐Nahhal IM, Salem J, Anbar R, et al. Preparation and antimicrobial activity of ZnO‐NPs coated cotton/starch and their functionalized ZnO‐Ag/cotton and Zn(II) curcumin/cotton materials. Sci Rep 2020; 10: 5410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Das MP, Jeyanthi L. Evaluation of antibacterial efficacy of biogenic zinc oxide nanoparticles on cotton fabrics. J Pharm Sci Res 2017; 9: 2553–2557. [Google Scholar]
- 66. Kar TR, Samanta AK, Sajid M, et al. UV protection and antimicrobial finish on cotton khadi fabric using a mixture of nanoparticles of zinc oxide and poly‐hydroxy‐amino methyl silicone. Text Res J 2019; 89: 2260–2278. [Google Scholar]
- 67. Huang J, Yang Y, Yang L, et al. Fabrication of multifunctional silk fabrics via one step in‐situ synthesis of ZnO. Mater Lett 2019; 237: 149–151. [Google Scholar]
- 68. Nourbakhsh S, Montazer M, Khandaghabadi Z. Zinc oxide nano particles coating on polyester fabric functionalized through alkali treatment. J Ind Text 2018; 47: 1006–1023. [Google Scholar]
- 69. Ashraf M, Siyal M, Nazir A, et al. Single‐step antimicrobial and moisture management finishing of PC fabric using ZNO nanoparticles. Autex Res J 2016; 17: 259–262. [Google Scholar]
- 70. Paul S, Basak S, Ali W. Zinc stannate nanostructure: is it a new class of material for multifunctional cotton textiles? ACS Omega 2019; 4: 21827–21838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Amani A, Montazer M, Mahmoudirad M. Synthesis of applicable hydrogel corn silk/ZnO nanocomposites on polyester fabric with antimicrobial properties and low cytotoxicity. Int J Biol Macromol 2019; 123: 1079–1090. [DOI] [PubMed] [Google Scholar]
- 72. Preethi S, Abarna K, Nithyasri M, et al. Synthesis and characterization of chitosan/zinc oxide nanocomposite for antibacterial activity onto cotton fabrics and dye degradation applications. Int J Biol Macromol 2020; 164: 2779–2787. [DOI] [PubMed] [Google Scholar]
- 73. Fiedot‐Toboła M, Ciesielska M, Maliszewska I, et al. Deposition of zinc oxide on different polymer textiles and their antibacterial properties. Materials (Basel) 2018; 11: 707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Hassabo AG, El‐Naggar ME, Mohamed AL, et al. Development of multifunctional modified cotton fabric with tri‐component nanoparticles of silver, copper and zinc oxide. Carbohydr Polym 2019; 210: 144–156. [DOI] [PubMed] [Google Scholar]
- 75. Holt BA, Gregory SA, Sulchek T, et al. Aqueous zinc compounds as residual antimicrobial agents for textiles. ACS Appl Mater Interfaces 2018; 10: 7709–7716. [DOI] [PubMed] [Google Scholar]
- 76. Wollina U, Schmidt N, Mühle D, et al. Clinical experiences with an antimicrobial bed equipment using zinc‐smartcel fibers for pronounced atopic dermatitis. J Appl Aesth 2019; 19–1 Cosmet Medicine. [Google Scholar]
- 77. Hoefer D. A real‐life based evaluation of the effectiveness of antibacterial fabrics in treating atopic dermatitis. Dermatol Res Pract 2018; 2018: 8 pages. 10.1155/2018/7043438 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Teli MD, Sheikh J. Modified bamboo rayon‐copper nanoparticle composites as antibacterial textiles. Int J Biol Macromol 2013; 61: 302–307. [DOI] [PubMed] [Google Scholar]
- 79. Hammer TR, Mucha H, Hoefer D. Dermatophyte susceptibility varies towards antimicrobial textiles. Mycoses 2012; 55: 344–351. [DOI] [PubMed] [Google Scholar]
- 80. Sharma P, Pant S, Dave V, et al. Green synthesis and characterization of copper nanoparticles by Tinospora cordifolia to produce nature‐friendly copper nano‐coated fabric and their antimicrobial evaluation. J Microbiol Methods 2019; 160: 107–116. [DOI] [PubMed] [Google Scholar]
- 81. Turalija M, Merschak P, Redl B, et al. Copper(i)oxide microparticles ‐ synthesis and antimicrobial finishing of textiles. J Mater Chem B 2015; 3: 5886–5892. [DOI] [PubMed] [Google Scholar]
- 82. Bhutiya PL, Misra N, Abdul Rasheed M, et al. Nested seaweed cellulose fiber deposited with cuprous oxide nanorods for antimicrobial activity. Int J Biol Macromol 2018; 117: 435–444. [DOI] [PubMed] [Google Scholar]
- 83. Vasantharaj S, Sathiyavimal S, Saravanan M, et al. Synthesis of ecofriendly copper oxide nanoparticles for fabrication over textile fabrics: characterization of antibacterial activity and dye degradation potential. J Photochem Photobiol B 2019; 191: 143–149. [DOI] [PubMed] [Google Scholar]
- 84. Irene G, Georgios P, Ioannis C, et al. Copper‐coated textiles: armor against MDR nosocomial pathogens. Diagn Microbiol Infect Dis 2016; 85: 205–209. [DOI] [PubMed] [Google Scholar]
- 85. Sójka‐Ledakowicz J, Chruściel JJ, Kudzin MH, et al. Antimicrobial functionalization of textile materials with copper silicate. Fibres Text East Eur 2016; 24: 151–156. [Google Scholar]
- 86. Imai K, Ogawa H, Bui VN, et al. Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite‐textile materials. Antiviral Res 2012; 93: 225–233. [DOI] [PubMed] [Google Scholar]
- 87. Marcus EL, Yosef H, Borkow G, et al. Reduction of health care‐associated infection indicators by copper oxide‐impregnated textiles: crossover, double‐blind controlled study in chronic ventilator‐dependent patients. Am J Infect Control 2017; 45: 401–403. [DOI] [PubMed] [Google Scholar]
- 88. Butler JP. Effect of copper‐impregnated composite bed linens and patient gowns on healthcare‐associated infection rates in six hospitals. J Hosp Infect 2018; 100: e130–e134. [DOI] [PubMed] [Google Scholar]
- 89. Lazary A, Weinberg I, Vatine JJ, et al. Reduction of healthcare‐associated infections in a long‐term care brain injury ward by replacing regular linens with biocidal copper oxide impregnated linens. Int J Infect Dis 2014; 24: 23–29. [DOI] [PubMed] [Google Scholar]
- 90. Dykes P. Increase in skin surface elasticity in normal volunteer subjects following the use of copper oxide impregnated socks. Skin Res Technol 2015; 21: 272–277. [DOI] [PubMed] [Google Scholar]
- 91. Gargiulo ME, Elías AC, Borkow G. Analysis of the effect of wearing copper oxide impregnated socks on tinea pedis based on “Before and After” pictures – a statistical follow‐up tool. Open Biol J 2012; 5: 17–22. [Google Scholar]
- 92. Baek JH, Yoo MA, Koh JS, et al. Reduction of facial wrinkles depth by sleeping on copper oxide‐containing pillowcases: a double blind, placebo controlled, parallel, randomized clinical study. J Cosmet Dtermatol 2012; 11: 193–200. [DOI] [PubMed] [Google Scholar]
- 93. Borkow G, Gabbay J, Lyakhovitsky A, et al. Improvement of facial skin characteristics using copper oxide containing pillowcases: a double‐blind, placebo‐controlled, parallel, randomized study. Int J Cosmet Sci 2009; 31: 437–443. [DOI] [PubMed] [Google Scholar]
- 94. Rehan M, Barhoum A, Van Assche G, et al. Towards multifunctional cellulosic fabric: UV photo‐reduction and in‐situ synthesis of silver nanoparticles into cellulose fabrics. Int J Biol Macromol 2017; 98: 877–886. [DOI] [PubMed] [Google Scholar]
- 95. Xu Q, Xie L, Diao H, et al. Antibacterial cotton fabric with enhanced durability prepared using silver nanoparticles and carboxymethyl chitosan. Carbohydr Polym 2017; 177: 187–193. [DOI] [PubMed] [Google Scholar]
- 96. Emam HE, Saleh NH, Nagy KS, et al. Functionalization of medical cotton by direct incorporation of silver nanoparticles. Int J Biol Macromol 2015; 78: 249–256. [DOI] [PubMed] [Google Scholar]
- 97. Li S, Zhu T, Huang J, et al. Durable antibacterial and UV‐protective Ag/TiO2@ fabrics for sustainable biomedical application. Int J Nanomedicine 2017; 12: 2593–2606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. El‐Rafie MH, Ahmed HB, Zahran MK. Characterization of nanosilver coated cotton fabrics and evaluation of its antibacterial efficacy. Carbohydr Polym 2014; 107: 174–181. [DOI] [PubMed] [Google Scholar]
- 99. Zhang D, Chen L, Zang C, et al. Antibacterial cotton fabric grafted with silver nanoparticles and its excellent laundering durability. Carbohydr Polym 2013; 92: 2088–2094. [DOI] [PubMed] [Google Scholar]
- 100. Gerba CP, Sifuentes LY, Lopez GU, et al. Wide‐spectrum activity of a silver‐impregnated fabric. Am J Infect Control 2016; 44: 689–690. [DOI] [PubMed] [Google Scholar]
- 101. Balakumaran MD, Ramachandran R, Jagadeeswari S, et al. In vitro biological properties and characterization of nanosilver coated cotton fabrics – an application for antimicrobial textile finishing. Int Biodeterior Biodegradation 2016; 107: 48–55. [Google Scholar]
- 102. Dhiman G, Chakraborty JN. Antimicrobial performance of cotton finished with triclosan, silver and chitosan. Fash Text 2015; 2: 13. [Google Scholar]
- 103. Pulit‐Prociak J, Chwastowski J, Kucharski A, et al. Functionalization of textiles with silver and zinc oxide nanoparticles. Appl Surf Sci 2016; 385: 543–553. [Google Scholar]
- 104. Shaheen TI, Abd El Aty AA. In‐situ green myco‐synthesis of silver nanoparticles onto cotton fabrics for broad spectrum antimicrobial activity. Int J Biol Macromol 2018; 118, 2121–2130. [DOI] [PubMed] [Google Scholar]
- 105. Rodrigues AG, Romano de Oliveira Gonçalves PJ, Ottoni CA, et al. Functional textiles impregnated with biogenic silver nanoparticles from Bionectria ochroleuca and its antimicrobial activity. Biomed Microdevices 2019; 21: 56. [DOI] [PubMed] [Google Scholar]
- 106. Ali SW, Rajendran S, Joshi M. Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester. Carbohydr Polym 2011; 83: 438–446. [Google Scholar]
- 107. Noor N, Mutalik S, Younas MW, et al. Durable antimicrobial behaviour from silver‐graphene coated medical textile composites. Polymers 2019; 11: 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Mofidfar M, Kim ES, Larkin EL, et al. Antimicrobial activity of silver containing crosslinked poly (acrylic acid) fibers. Micromachines 2019; 10: 829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Rehan M, Khattab TA, Barohum A, et al. Development of Ag/AgX (X = Cl, I) nanoparticles toward antimicrobial, UV‐protected and self‐cleanable viscose fibers. Carbohydr Polym 2018; 197: 227–236. [DOI] [PubMed] [Google Scholar]
- 110. Tremiliosi GC, Simoes LGP, Minozzi DT, et al. Ag nanoparticles‐based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS‐CoV‐2. bioRxiv 2020. 10.1101/2020.06.26.152520. [DOI] [Google Scholar]
- 111. Ibănescu M, Muşat V, Textor T, et al. Photocatalytic and antimicrobial Ag/ZnO nanocomposites for functionalization of textile fabrics. J Alloys Compd 2014; 610: 244–249. [Google Scholar]
- 112. Shin YS, Park M, Kim HY, et al. Synthesis of silver‐doped silica‐complex nanoparticles for antibacterial materials. Bull Korean Chem Soc 2014; 35: 2979–2984. [Google Scholar]
- 113. Nischala K, Rao TN, Hebalkar N. Silica‐silver core‐shell particles for antibacterial textile application. Colloids Surf B Biointerfaces 2011; 82: 203–208. [DOI] [PubMed] [Google Scholar]
- 114. Juenger M, Ladwig A, Staecker S, et al. Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin 2006; 22: 739–750. [DOI] [PubMed] [Google Scholar]
- 115. Araújo CP, Gomes J, Vieira AP, et al. A proposal for the use of new silver‐seaweed‐cotton fibers in the treatment of atopic dermatitis. Cutan Ocul Toxicol 2013; 32: 268–274. [DOI] [PubMed] [Google Scholar]
- 116. Hoefer D, Hammer TR. Antimicrobial active clothes display no adverse effects on the ecological balance of the healthy human skin microflora. Int Scholar Res Notices 2011; 2011: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]